Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
92,315,749
-
Total 13F shares
-
107,325,713
-
Share change
-
-4,862,019
-
Total reported value
-
$3,502,008,205
-
Put/Call ratio
-
110%
-
Price per share
-
$32.63
-
Number of holders
-
254
-
Value change
-
-$266,640,575
-
Number of buys
-
143
-
Number of sells
-
142
Institutional Holders of Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) as of Q4 2017
As of 31 Dec 2017 Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) had 254 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 107,325,713 shares of stock of the company.
Largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, Vanguard Group Inc, Aristotle Capital Management, LLC, GOLDMAN SACHS GROUP INC, Invesco Ltd., P2 Capital Partners, LLC, and FRONTIER CAPITAL MANAGEMENT CO LLC.
This table shows 254 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.